Clinical and molecular impact of concurrent thyroid autoimmune disease and thyroid cancer: From the bench to bedside
{{output}}
The recent incorporation of immune checkpoint inhibitors targeting the PD-1 (programmed cell death receptor 1) and CTLA-4 (cytotoxic T lymphocyte antigen 4) pathways into the therapeutic armamentarium of cancer has increased the need to understand the correlat... ...
